Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Located in the heart of Newport Beach at 200 Newport Center Dr
The Phase 2b OPTIONS trial 536 obese subjects, randomized to receive 0.25, 0.5, or 1 mg/day oral AOD-9604 or placebo over 24 weeks failed to demonstrate statistically significant weight loss at any dose tested
LC-MS allows you to confirm the actual mass and profile of the compound
Historically, scientists have referred to this compound by various names, including Growth-modulating peptide and Liver growth factor Cu-GHK, reflecting its diverse biological activity throughout the body
US$ 22.32
US$ 25.50
US$ 26.23
US$ 26.35
US$ 23.63
